Adult Vaccines: Fact vs. Fiction
Addressing patient misconceptions and uncertainty remains important to help get routine adult vaccinations back on schedule.
Experimental mRNA Vaccine Plus Keytruda Delays Melanoma Recurrence
A new study shows that a personalized messenger RNA (mRNA) cancer vaccine plus the checkpoint inhibitor Keytruda (pembrolizumab) reduced the risk of recurrence or death in people with high-risk advanced melanoma.
The Spread of Misinformation and Its Effects on Vaccines
The effects of exposure to misinformation about vaccines has been exacerbated by the COVID-19 pandemic. And, misinformation continues to flourish with damaging consequences.
Personalized Cancer Vaccine Development
Research into targeted, effective vaccines for cancer remains ongoing.
mRNA-Based Vaccine Plus Keytruda Reduces the Risk of Melanoma Spread
Adding an experimental mRNA-based vaccine developed by Moderna and Merck & Co to Keytruda reduced the risk that melanoma would spread by 65 percent over treatment with the immunotherapy drug alone, according to a midstage trial.
Study Finds Meningitis Vaccine Shows Promise
According to a new study, a meningitis vaccine tested in two African countries has shown promise in the fight against the disease, eliciting immune responses against five main strains. The Phase III randomized trials were conducted on 1,800 people in the West African nations of Mali and The Gambia. The under-trial NmCV-5 vaccine, developed by […]
CDC Adds COVID-19 Vaccine to Its Routine Immunization Schedule
The Centers for Disease Control and Prevention updated its schedule of recommended immunizations to include COVID-19 shots and boosters for children, adolescents and adults.
Regen BioPharma Files Patent for mRNA Cancer Vaccine
Regen BioPharma has filed a provisional patent application covering utilization of dendritic cell technologies to augment efficacy of its patented mRNA cancer immunotherapeutic vaccine.
First Malaria Vaccine Prequalified by WHO
The World Health Organization has prequalified the first malaria vaccine, RTS,S/AS01 (also known as Mosquirix), manufactured by GSK, bringing it closer to reaching millions more children at risk of malaria.
Study Finds Universal Influenza B Vaccine Induces Broad and Lasting Protection
A study by researchers at Georgia State University’s Institute of Biomedical Sciences has found a new universal flu vaccine has been found to protect against influenza B viruses that offer broad defenses against different strains and improve immune protection.
